DMP1を新しいp53抑制された転写標的として識別
Jun Xu1,2, Christian Britschgi3, Gustav Arvidsson1
1Institute of Tissue Medicine and Pathology, Division of Experimental Pathology, University of Bern, CH-3008 Bern, Switzerland.
International journal of molecular sciences
|February 13, 2026
まとめ
腫瘍抑制剤p53は,DMP1遺伝子発現を直接抑制する. この抑制はSp1によって媒介され,細胞サイクル制御とアポトーシスにとって極めて重要なARF-p53経路に影響を与えます.
科学分野:
- 分子生物学は分子生物学である.
- がん研究 がん研究
- 遺伝子規制 遺伝子規制
背景:
- DMP1は,腫瘍抑制剤ARFの陽性調節剤である.
- ARFはp53.3を介して細胞サイクル進行とアポトーシスを制御する.
- p53とDMP1発現の関係については未調査でした.
研究 の 目的:
- p53転写因子がDMP1の発現を調節するかどうかを調査する.
- DMP1.1のp53媒介調節の分子メカニズムを解明する.
主な方法:
- 繊維芽細胞における温度感受性p53誘導を利用した.
- MCF7の乳がん細胞でp53をノックダウンした.
- hDMP1プロモーター活性,デレーション分析,クロマチンの免疫プレシピテーションアッセイを分析した.
主要な成果:
- p53誘導は内在的なhDMP1mRNAレベルを低下させた.
- p53ノックダウンにより,hDMP1 mRNAとタンパク質のレベルが上昇した.
- p53は,直接のp53結合部位とは独立して,Sp1-依存的な方法でhDMP1プロモーター活性を抑制した.
結論:
- p53は,DMP1の遺伝子発現を直接抑制する.
- Sp1は,DMP1.1のp53媒介抑制に不可欠である.
- これは,ARF-p53経路で細胞の運命に影響を与える新しい規制ループを特定します.
キーワード:
DMP1 についてDMTF1 (DMTF1) DMTF1 (DMTF1) DMTF1 (DMTF1) DMTF1 (DMTF1) DMTF1 (DMTF1) DMTF1 (DMTF1) DMTF1 (DMTF1) DMTF1 (DMTF1) DMTF1 (DMTF1) DMTF1 (DMTF2) DMTF1 (DMTF1) DMTF1 (DMTF2) DMTF1 (DMTF1) DMTF1 (DMTF2) DMTF1 (DMTF2) DMTF1 (DMTF1) DMTF1 (DMTF2) DMTF1 (DMTF1)hDMP1 についてmDmp1mDmp1mDmp1 mDmp1mDmp1 mDmp1mDmp1 mDmp1mDmp1 mDmp1mDmp1 mDmp1ネガティブなフィードバックが返ってきます.p53 p53 について関連する概念動画
Eukaryotic Transcription Inhibitors
11.1K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
Pharmacogenomics: Identification of New Drug Targets
3
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
3
Repressed Memory
529
Repressed memories are a psychological phenomenon where memories of traumatic events are unconsciously blocked from a person's awareness. This process occurs as a defense mechanism, protecting the mind from the emotional impact of distressing or painful experiences. For example, a person who has experienced childhood trauma may grow up with no conscious recollection of the event. In such cases, the memories are thought to be buried deep within the subconscious, inaccessible to the conscious...
529
Transcription
157.1K
Overview
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...
157.1K
Transcription Factors
82.9K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.9K
Repressible Operon: trp Operon
1.8K
The trp operon in Escherichia coli exemplifies a repressible operon. It regulates the synthesis of tryptophan through repressor-mediated transcriptional control and attenuation. This dual regulatory mechanism ensures tryptophan biosynthesis occurs only when needed, conserving cellular resources.Structure of the trp OperonThe trp operon consists of five structural genes (trpE, trpD, trpC, trpB, and trpA) that encode enzymes for tryptophan biosynthesis. These genes are transcribed as a single...
1.8K


